A Randomized, Evaluator-blinded Study to Evaluate Skin Irritation and Sensitization of d-Amphetamine Transdermal System in Healthy Adults
Latest Information Update: 26 Aug 2020
At a glance
- Drugs Dexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Adverse reactions
- Acronyms dATS
- Sponsors Noven Pharmaceuticals
Most Recent Events
- 20 Aug 2020 Status changed from recruiting to completed.
- 12 Nov 2019 Status changed from not yet recruiting to recruiting.
- 24 Sep 2019 New trial record